SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-003045
Filing Date
2023-02-10
Accepted
2023-02-10 16:20:33
Documents
13
Period of Report
2023-02-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20230210_8k.htm   iXBRL 8-K 24778
  Complete submission text file 0001437749-23-003045.txt   156552

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbla-20230209.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20230209_def.xml EX-101.DEF 11532
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20230209_lab.xml EX-101.LAB 15414
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20230209_pre.xml EX-101.PRE 11688
7 EXTRACTED XBRL INSTANCE DOCUMENT pbla20230210_8k_htm.xml XML 2554
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 23612237
SIC: 2834 Pharmaceutical Preparations